Saturday 17 October 2026
Export NUTX’s income statement to Excel — free account
Nutex Health Inc.
NUTX Healthcare Medical Care Facilities
Nutex Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $875.3 million, up 82.4% from fiscal 2024. In the quarter to June 2026, revenue fell 13.6%, EPS grew 424.8%, free cash flow grew 19.4% and total debt fell 1.69%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
185.95
14.85
−7.40%
Follow NUTX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
7 | 7 | 5 | 3 | 5 | 6 | 2 | — | — | — |
P/E ratio |
17.38 | 3.19 | 0.00 | 0.00 | 70.50 | 70.50 | 70.50 | 70.50 | 70.50 | — |
Altman Z-Score |
3.27 | 1.09 | (0.76) | (1.33) | — | — | — | — | — | — |
P/S ratio |
1.20 | 0.34 | 0.53 | 5.76 | 58.05 | 58.05 | 58.05 | 58.05 | 58.05 | — |
P/FCF ratio |
4.26 | 7.74 | 0.00 | 35.12 | 144.46 | 144.46 | 144.46 | 144.46 | 144.46 | — |
Altman Z″-Score (non-manufacturers) |
4.62 | 1.37 | (3.09) | (8.01) | 6.67 | 5,669.46 | (15.95) | (63.71) | (20.13) | — |
Beneish M-Score |
(2.54) | (0.66) | (3.38) | (5.05) | 4,806.18 | 1,792.72 | (4.33) | 38.62 | — | — |
P/Operating CF |
14.88 | 2,987.55 | (74.48) | 280.38 | 663.75 | 663.75 | 663.75 | 663.75 | 663.75 | — |
Dividend Safety Score |
41 | — | — | — | — | — | — | — | — | — |
P/B ratio |
2.47 | 0.86 | 1.67 | 10.50 | 328.93 | 328.93 | 328.93 | 328.93 | 328.93 | — |
Price to Tangible BV |
2.70 | 1.01 | 3.18 | 15.38 | 6,143.41 | 6,143.41 | 6,143.41 | 6,143.41 | 6,143.41 | — |
EV/Sales |
1.33 | 0.87 | 1.47 | 6.71 | 58.03 | 58.03 | 58.03 | 58.03 | 58.03 | — |
EV/EBITDA |
3.92 | 2.78 | 0.00 | 0.00 | 111.00 | 111.00 | 111.00 | 111.00 | 111.00 | — |
EV/Operating CF |
4.68 | 18.04 | 290.08 | 29.07 | 113.07 | 113.07 | 113.07 | 113.07 | 113.07 | — |
EV/FCF |
4.72 | 20.03 | (44.25) | 40.89 | 144.40 | 144.40 | 144.40 | 144.40 | 144.40 | — |
Quick Ratio |
3.24 | 1.81 | 1.45 | 1.69 | 4.00 | 0.04 | 0.25 | 0.29 | 0.02 | 0.00 |
Current Ratio |
3.41 | 1.90 | 1.56 | 1.79 | 4.09 | 0.14 | 0.27 | 0.29 | 0.06 | 0.08 |
Net Debt/EBITDA |
0.43 | 1.71 | (16.39) | (0.53) | 0.67 | 0.00 | (0.19) | (1.15) | (0.06) | (0.09) |
Debt/Assets |
33.98% | 45.76% | 63.88% | 56.01% | 39.22% | 290.11% | 34.90% | 240.28% | 10.02% | 9.79% |
Debt/Equity |
0.74 | 1.59 | 3.22 | 2.01 | 0.81 | (0.43) | 1.26 | (0.72) | 0.14 | (0.01) |
Asset Turnover |
1.11 | 0.91 | 0.60 | 0.53 | 1.68 | 79.86 | 0.38 | 0.72 | 0.01 | 0.00 |
Operating CF/Net income |
3.51 | 0.44 | (0.03) | (0.12) | 1.31 | 0.82 | 0.57 | 0.51 | (1.23) | 0.04 |
Capex/Depreciation |
(0.12) | (0.12) | (0.54) | (1.11) | (4.82) | (10.37) | (0.49) | 0.00 | 0.00 | 0.00 |
Interest Coverage |
12.40 | 6.56 | (1.95) | (32.55) | 27.48 | 23.81 | (74.81) | (7.65) | (15.50) | (172.54) |
| 23.13% | 38.93% | (45.92%) | (272.38%) | 139.24% | 29,249.21% | (3,942.66%) | (218.01%) | (33.26%) | 0.00% | |
| 9.00% | 9.89% | (11.03%) | (102.80%) | 67.17% | 3,088.42% | (199.29%) | (50.29%) | 30.32% | (2,910.02%) | |
ROIC |
31.34% | 18.36% | (6.38%) | (77.50%) | 34.30% | 0.00% | (137.79%) | 0.00% | (132.11%) | 0.00% |
Return on Tangible Assets |
14.89% | 24.10% | (40.19%) | (339.27%) | 49.43% | (10,767.11%) | 216.72% | 129.95% | (64.61%) | 126.59% |
Average Days of Receivables |
135.71 | 179.52 | 92.52 | 97.06 | 126.34 | 0.02 | 26.77 | 49.72 | 99.12 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 56.21% | 39.88% | 110.34% | — |
Selling, General and Administrative Expense of Revenue |
19.27% | 12.18% | 14.56% | 9.12% | 1.65% | 1.62% | 310.66% | 84.46% | 7,817.24% | 0.00% |
Intangible Assets out of Total Assets |
0.04 | 0.04 | 0.09 | 0.09 | 0.00 | 0.00 | 0.75 | 0.00 | 0.98 | 0.00 |
Share Based Compensation of Revenue |
13.37% | 3.45% | 1.15% | 0.09% | 1.21% | 0.94% | 32.94% | 11.40% | 3,984.05% | 0.00% |
Graham Net Nets |
0.04 | (1.08) | (1.73) | (0.17) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Graham Number |
119.09 | 91.01 | 0.00 | 0.00 | 215.56 | 0.00 | 0.00 | 497.27 | 5,026.86 | — |
Earnings Yield |
5.75% | 31.37% | (38.23%) | (33.05%) | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | — |
Free Cash Flow Yield |
23.45% | 12.92% | (6.23%) | 2.85% | 0.69% | 0.69% | 0.69% | 0.69% | 0.69% | — |
Revenue per Share |
137.59 | 94.28 | 56.18 | 51.81 | 83.85 | 69.31 | 56.46 | 119.91 | 21.09 | 0.00 |
Operating CF per Share |
39.00 | 4.55 | 0.29 | 11.96 | 43.86 | 21.92 | (166.97) | (42.11) | (649.64) | (548.40) |
Capex per Share |
(0.40) | (0.45) | (2.15) | (3.46) | (9.34) | (15.48) | (3.47) | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
38.61 | 4.10 | (1.87) | 8.50 | 34.52 | 6.45 | (170.44) | (42.11) | (649.64) | (548.40) |
Cash per Share |
29.22 | 8.56 | 4.99 | 8.09 | 9.13 | 0.01 | 44.02 | 10.46 | 8.55 | 21.00 |
Shareholders Equity per Share |
66.56 | 37.03 | 17.94 | 28.43 | 48.45 | (0.29) | 76.79 | (131.35) | 2,153.64 | (11,738.80) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
66.56 | 37.03 | 17.94 | 28.43 | 48.45 | (0.29) | 76.79 | (131.35) | 2,153.64 | (11,738.80) |
Free Cash Flow |
245.60 | 20.85 | (8.24) | 35.97 | 136.51 | 25.48 | (4.12) | (0.48) | (0.71) | (0.27) |
Working Capital |
380.90 | 138.25 | 32.54 | 43.11 | 116.32 | (1.00) | (3.37) | (0.74) | (0.90) | (5.87) |
Capital Expenditures |
(2.53) | (2.30) | (9.50) | (14.63) | (36.93) | (61.19) | (0.08) | — | — | — |
Net Current Asset Value |
43.72 | (174.31) | (228.29) | (213.45) | (49.05) | (1.15) | (3.59) | (1.64) | (0.90) | (5.87) |
EV/EBIT |
4.21 | 3.20 | 0.00 | 0.00 | 116.45 | 116.45 | 116.45 | 116.45 | 116.45 | — |
Capex to Sales |
0.00 | 0.00 | 0.04 | 0.07 | 0.11 | 0.22 | 0.06 | 0.00 | 0.00 | — |
Price to Operating Income |
3.80 | 1.23 | 0.00 | 0.00 | 116.49 | 116.49 | 116.49 | 116.49 | 116.49 | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.22 | 0.25 | 0.22 | 0.16 | 0.05 | 475.68 | 2.06 | 0.42 | 140.79 | 0.42 |
Cash ROIC |
26.65% | 3.92% | (2.32%) | 9.07% | 35.69% | (4,150.33%) | (78.42%) | 160.91% | (26.35%) | 4.72% |
Accounts Receivable Turnover |
3.12 | 3.21 | 4.09 | 2.53 | 5.78 | 4,624.96 | 9.54 | 14.20 | 0.00 | — |
Accounts Payable Turnover |
14.51 | 15.89 | 8.06 | 9.02 | 16.60 | 95.11 | 0.72 | 1.11 | 0.09 | — |
Inventory Turnover |
150.80 | 90.92 | 61.49 | 64.24 | 107.17 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
41.47 | 13.41 | 43.35 | 49.29 | 42.32 | 2.18 | 770.39 | 407.71 | 4,169.38 | 0.00 |
Days of Inventory on Hand |
2.43 | 3.67 | 5.81 | 6.33 | 6.75 | 0.00 | 11.87 | 0.00 | 0.00 | — |
Average Receivables |
280.73 | 149.41 | 60.55 | 86.54 | 57.39 | 0.06 | 0.14 | 0.10 | — | — |
Average Payables |
29.69 | 17.85 | 26.41 | 22.59 | 9.17 | 1.22 | 1.16 | 0.46 | 0.35 | — |
Average Inventory |
2.86 | 3.12 | 3.46 | 3.17 | 1.42 | — | — | — | — | — |
Average Assets |
786.92 | 526.78 | 415.00 | 413.20 | 197.41 | 3.43 | 3.57 | 1.89 | 1.92 | 0.26 |
Average Common Equity |
305.99 | 133.82 | 99.72 | 155.95 | 95.22 | 0.36 | 0.18 | 0.44 | (1.75) | — |
Columns are period end dates